Y Combinator portfolio AI companies

Pulling your hair out in clinical trials because of spreadsheet madness?You’re not alone. Most biotech teams lose weeks, if not months, to manual spreadsheet trackers, delayed insights, and inadequate vendor oversight.That’s exactly why we built Miracle.👉 Speed: Replace clunky manual trackers with an integrated platform that gets you live in just days (not weeks or months).👉 Clarity: Real-time visibility across trials, so your execs stop asking you for “one quick update” every day.👉 Proof: Clinical-stage biotechs using Miracle have already finished 3-4 months ahead of trial timelines, freeing their teams from spreadsheet hell and resolving risks as soon as they occur, not next week.If you’re a biotech exec staring down another delayed trial (or want to start your study on the right foot), Miracle can help you close the gap.📩 Message us here or reach out at https://www.miracleml.com/contactLet’s make “trial delays” something you don’t talk about next quarter.

• Seed
• 75 employees
• Founded 2022

Imagine a world without chocolate. Horrifying, right? But the supply of cocoa is endangered and chocolate is as bad as meat for our planet.We make future-proof chocolate using precision fermentation. Doing this, our chocolate is 10x more sustainable and 20% cheaper than conventional chocolate. In order to mimic the organoleptic properties of chocolate (tender, smoothly melting taste release) we are working on the flavor itself but also on replacing the cocoa butter.55 Mio lbs of chocolate are consumed every day. By 2035 we will substitute a big chunk of it through our sustainable chocolate.

• Corporate
• 74 employees
• Founded 2021

Zack Abbott, PhD microbiologist, founded ZBiotics because of the potential genetically engineered probiotics have to improve daily living. ZBiotics is leveraging its patented technology to create a whole new category of products that help our bodies deal with whatever modern life throws our way. It’s genetic engineering as it should be: transparent, responsible, and people-first.

• Secondary
• 69 employees
• Founded 2016

Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x.The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team.We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing a 100 year old industry and becoming the standard infrastructure that the world of biotech relies on. Our customers already include global leaders in food, agriculture and biologicals. We’re backed by top tier investors from Y Combinator, CEOs from the industry and some of the biggest names you can find. At Reshape Biotech, you have the potential to influence how biotech research is done in the next 100 years.

• Series A
• 63 employees
• Founded 2018

Culture is your bioreactor lab, in the cloud.We help scientists accelerate bioprocess development with our high-throughput bioreactor cloud lab. You design your experiment, and we execute the experiment in our lab using our 250mL bioreactors. We take care of the high-quality execution so that you can focus on developing processes. While your experiment runs in our lab, you can monitor and analyze your data in real time using our online dashboard. With Culture, get faster insights to make better, data-driven decisions.

• Series C
• 61 employees
• Founded 2016